Skip to main content
Log in

Does MEST-C score predict outcomes in pediatric Henoch-Schönlein purpura nephritis?

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Background

Children with Henoch-Schönlein purpura nephritis (HSPN) have an increased risk of chronic kidney disease (CKD). Renal biopsy diagnostic of HSPN is graded using the International Study of Kidney Disease in Children criteria, which do not predict outcomes. The 2016 Oxford Classification’s MEST-C scoring system predicts outcomes in adults with histologically identical IgA nephropathy, but evidence of its utility in pediatric HSPN is lacking. Our hypothesis was that MEST-C scores predict outcomes in children with HSPN.

Methods

A retrospective cohort analysis of data from 32 children with HSPN who underwent renal biopsy was performed. We used logistic regression and receiver operator characteristic curves to analyze the ability of MEST-C to predict the composite outcome of hypertension (blood pressure ≥ 95% for age/sex/height), CKD (estimated glomerular filtration rate < 90 mL/min/1.73 m2), or proteinuria (urine protein-to-creatinine ratio > 0.2 mg/mg).

Results

The median age at diagnosis was 7.9 years (IQR 5.8, 11.7); 56% were male, 19% were Hispanic, and 9% were Black. After a median follow-up of 2.7 years, 38% of patients (n = 12) reached the outcome. S1 score was significantly associated with the outcome (OR 7.9, 95% CI 1.5–42.6). S1 accurately predicted the outcome (area under the curve 0.72, 95% CI 0.55–0.88) with 58.3% sensitivity and 85.0% specificity, indicating a positive predictive value of 70.0% and a negative predictive value of 77.3%.

Conclusions

S1 accurately predicted our composite outcome of hypertension, CKD, and proteinuria in a diverse cohort of U.S. children with HSPN. Further investigation is warranted to validate these findings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data availability

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

Abbreviations

eGFR:

Estimated glomerular filtration rate

CKD:

Chronic kidney disease

HSPN:

Henoch-Schönlein purpura nephritis

IQR:

Interquartile range

ISKDC:

The International Study of Kidney Disease in Children

IgAN:

IgA nephropathy

ROC:

Receiver operator characteristics

UPCR:

Urine protein-to-creatinine ratio

References

  1. Davin J, Ten Berge I, Weening J (2001) What is the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis? Kidney Int 59:823–834. https://doi.org/10.1046/j.1523-1755.2001.059003823.x

    Article  CAS  Google Scholar 

  2. Hahn D, Hodson E, Willis N, Craig J (2015) Interventions for preventing and treating kidney disease in Henoch-Schönlein purpura (HSP). Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD005128.pub3

  3. Schärer K, Krmar R, Querfeld U, Ruder H, Waldherr R, Schaefer F (1999) Clinical outcome of Schönlein-Henoch purpura nephritis in children. Pediatr Nephrol 13:816–823. https://doi.org/10.1007/s004670050707

    Article  PubMed  Google Scholar 

  4. Chen J, Mao J (2015) Henoch-Schönlein purpura nephritis in children: incidence, pathogenesis and management. World J Pediatr 11:29–34. https://doi.org/10.1007/s12519-014-0534-5

    Article  CAS  PubMed  Google Scholar 

  5. Narchi H (2005) Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child 90:916–920. https://doi.org/10.1136/adc.2005.074641

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Davin J (2011) Henoch-Schonlein purpura nephritis: pathophysiology, treatment, and future strategy. Clin J Am Soc Nephrol 6:679–689. https://doi.org/10.2215/CJN.06710810

    Article  PubMed  Google Scholar 

  7. Coppo R, Andrulli S, Amore A, Gianoglio B, Conti G, Peruzzi L, Locatelli F, Cagnoli L (2006) Predictors of outcome in Henoch-Schönlein nephritis in children and adults. Am J Kidney Dis 47:993–1003. https://doi.org/10.1053/j.ajkd.2006.02.178

    Article  PubMed  Google Scholar 

  8. Davin J, Coppo R (2013) Pitfalls in recommending evidence-based guidelines for a protean disease like Henoch–Schönlein purpura nephritis. Pediatr Nephrol 28:1897–1903. https://doi.org/10.1007/s00467-013-2550-4

    Article  PubMed  Google Scholar 

  9. Soylemezoglu O, Ozkaya O, Ozen S, Bakkaloglu A, Dusunel R, Peru H, Donmez O, Buyan N, Mir S, Gur-Guven A, Alpay H, Ekim M, Aksu N, Soylu A, Gok F, Poyrazoglu H, Sonmez F (2009) Henoch-Schonlein nephritis: a nationwide study. Nephron Clin Pract 112:c199–c204. https://doi.org/10.1159/000218109

    Article  CAS  PubMed  Google Scholar 

  10. Foster B, Bernard C, Drummond K, Sharma A (2000) Effective therapy for severe Henoch-Schonlein purpura nephritis with prednisone and azathioprine: a clinical and histopathologic study. J Pediatr 136:370–375. https://doi.org/10.1067/mpd.2000.103448

    Article  CAS  Google Scholar 

  11. Coppo R, Mazzucco G, Cagnoli L, Lupo A, Schena F (1997) Long-term prognosis of Henoch-Schönlein nephritis in adults and children. Italian Group of Renal Immunopathology collaborative study on Henoch-Schönlein purpura. Nephrol Dial Transplant 12:2277–2283

    Article  CAS  Google Scholar 

  12. Ronkainen J, Nuutinen M, Koskimies O (2002) The adult kidney 24 years after childhood Henoch-Schönlein purpura: a retrospective cohort study. Lancet 360:666–670. https://doi.org/10.1016/S0140-6736(02)09835-5

    Article  PubMed  Google Scholar 

  13. Trimarchi H, Barratt J, Cattran DC, Cook T, Coppo R, Haas M, Liu Z, Roberts I, Yuzawa Y, Zhang H, Feehally J, Alpers C, Asunis A, Barbour S, Becker J, Ding J, Espino G, Ferrario F, Fogo A, Hladunewich M, Joh K, Katafuchi R, Matsuzaki K, Nakanishi K, Pani A, Perera R, Perkowska A, Reich H, Shima Y, Soares M, Suzuki Y, Takahashi K, Troyanov S, Verhave J, Wang S, Weening J, Wyatt R, Yoshikawa N, Zeng C (2017) Oxford classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. Kidney Int 91:1014–1021. https://doi.org/10.1016/j.kint.2017.02.003

    Article  PubMed  Google Scholar 

  14. Roberts I, Cook H, Troyanov S, Alpers C, Amore A, Baratt J, Berthoux F, Bonsib S, Bruijin J, Cattran D, Coppo R, D’Agati V, Amico G, Emancipator S, Emma F, Feehally J, Ferrario F, Fervenza F, Florquin S, Fogo A, Geddes C, Groene H, Herzenberg A, Hill P, Hogg R, Hsu S, Jennette C, Joh K, Julian B, Kawamura T, Lai F, Li L, Li P, Liu Z, Macjinnon B, Mezzano S, Schena P, Tomino Y, Walker P, Wang H, Weening J, Yoshikawa N, Zhang H (2009) The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int 76:546–556. https://doi.org/10.1038/ki.2009.168

    Article  PubMed  Google Scholar 

  15. Magistroni R, D’Agati V, Appel G, Kiryluk K (2015) New developments in the genetics, pathogenesis, and therapy of IgA nephropathy. Kidney Int 88:974–989. https://doi.org/10.1038/ki.2015.252

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Jennette J (2006) Immunoglobin A nephropathy and Henoch-Schonlein purpura. In: Fundamentals of renal pathology. Springer, New York, pp 61–69

    Google Scholar 

  17. Xu K, Zhang L, Ding J, Wang S, Su B, Xiao H, Wang F, Zhong X, Ly Y (2018) Value of the Oxford classification of IgA nephropathy in children with Henoch–Schönlein purpura nephritis. J Nephrol 31:279–286. https://doi.org/10.1007/s40620-017-0457-z

    Article  PubMed  Google Scholar 

  18. Szeto C, Choi P, To K, Li P, Hui J, Chow K, Leung K, Lui S, Mac-Moune L (2001) Grading of acute and chronic renal lesions in Henoch-Schönlein purpura. Mod Pathol 14:635–640. https://doi.org/10.1038/modpathol.3880364

    Article  CAS  PubMed  Google Scholar 

  19. Pohl M (2015) Henoch–Schönlein purpura nephritis. Pediatr Nephrol 30:245–252. https://doi.org/10.1007/s00467-014-2815-6

    Article  PubMed  Google Scholar 

  20. (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555

  21. Ginsberg J, Chang B, Matarese R, Garella S (1983) Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med 309:1543–1546. https://doi.org/10.1056/NEJM198312223092503

    Article  CAS  PubMed  Google Scholar 

  22. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO (2012) Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3:1–150

    Google Scholar 

  23. Inker L, Schmid C, Tighiouart H, Feldmen H, Greene T, Kusek J, Manzi J, Van Lente F, Zhang Y, Coresh J, Levey A (2012) Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367:20–29. https://doi.org/10.1056/NEJMoa1114248

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D (2002) Henoch-Schonlein purpura in adults: outcome and prognostic factors. J Am Soc Nephrol 13:1271–1278. https://doi.org/10.1097/01.ASN.0000013883.99976.22

    Article  Google Scholar 

  25. Edström Halling S, Söderberg M, Berg U (2009) Treatment of severe Henoch–Schönlein and immunoglobulin A nephritis. A single center experience. Pediatr Nephrol 24:91–97. https://doi.org/10.1007/s00467-008-0990-z

    Article  PubMed  Google Scholar 

  26. Ho Kim C, Jin Lim B, Sung Bae Y, Eun Kwon Y, Heon Nam K, Sook Park K, Yeong An S, Mo Koo H, Mee Doh F, Jung Lee M, Jung OH, Yoo T, Kang S, Hun Choi K, Joo Jeong H, Han Seung H (2014) Using the Oxford classification of IgA nephropathy to predict long-term outcomes of Henoch–Schönlein purpura nephritis in adults. Mod Pathol 27:972–982. https://doi.org/10.1038/modpathol.2013.222

    Article  CAS  Google Scholar 

  27. Levey A, Eckardt K, Tsukamoto Y, Levin A, Coresh J, Rossert J, Zeeuw D, Hostetter T, Lameire N, Eknoyan G (2005) Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67:2089–2100. https://doi.org/10.1111/j.1523-1755.2005.00365.x

    Article  Google Scholar 

  28. Shin J, Park J, Shin Y, Kim J, Lee J, Kim P, Jeong H (2005) Can azathioprine and steroids alter the progression of severe Henoch-Schönlein nephritis in children? Pediatr Nephrol 20:1087–1092. https://doi.org/10.1007/s00467-005-1869-x

    Article  Google Scholar 

  29. Kanai H, Sawanobori E, Kobayashi A, Matsishita K, Sugita K, Higashida K (2011) Early treatment with methylprednisolone pulse therapy combined with tonsillectomy for heavy proteinuric Henoch-Schönlein purpura nephritis in children. Nephron Extra 1:101–111. https://doi.org/10.1159/000333010

    Article  PubMed  PubMed Central  Google Scholar 

  30. Niaudet P, Habib R (1998) Methylprednisolone pulse therapy in the treatment of severe forms of Schönlein-Henoch purpura nephritis. Pediatr Nephrol 12:238–243

    Article  CAS  Google Scholar 

  31. Delbet J, Hogan J, Aoun B, Stoica I, Salomon R, Decramer S, Brocheriou I, Deschenes G, Ulinski T (2017) Clinical outcomes in children with Henoch–Schönlein purpura nephritis without crescents. Pediatr Nephrol 32:1193–1199. https://doi.org/10.1007/s00467-017-3604-9

    Article  PubMed  Google Scholar 

  32. Tanaka H, Suzuki K, Nakahata T, Ito E, Waga S (2003) Early treatment with oral immunosuppressants in severe proteinuric purpura nephritis. Pediatr Nephrol Berl Ger 18:347–350. https://doi.org/10.1007/s00467-003-1094-4

    Article  Google Scholar 

  33. Iijima K, Ito-Kariya S, Nakamura H, Yoshikawa N (1998) Multiple combined therapy for severe Henoch-Schönlein nephritis in children. Pediatr Nephrol 12:244–248. https://doi.org/10.1007/s004670050447

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to thank Dan P. Goldstein and Marcia Voigt for their assistance with the collection of the data.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Adam Jimenez.

Ethics declarations

The Wake Forest School of Medicine Institutional Review Board approved the study.

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jimenez, A., Chen, A., Lin, JJ. et al. Does MEST-C score predict outcomes in pediatric Henoch-Schönlein purpura nephritis?. Pediatr Nephrol 34, 2583–2589 (2019). https://doi.org/10.1007/s00467-019-04327-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-019-04327-2

Keywords

Navigation